Patent buyouts could spur vital innovation in antibiotics, vaccines, and other medical fields

A patent is only valuable if there is a market for the drug, skewing the incentives for innovation. Patent buyouts offer another way forward.

By James B. Rebitzer and Robert S. Rebitzer - Stat First Opinion